TRU-SENTIMENT · DeltaNeutral
ALEC Trading Analysis - 10/07/2026 11:47 AM — TRU-SENTIMENT
Options chain · Stock chart · Baseline chart
ALEC (Alector Inc. Common Stock) at $1.78. True Sentiment Bullish, delta 40-60 call 65% / put 35%, call $600 vs put $320. RSI 42.3.
- Symbol
- ALEC
- Price
- $1.78
- Article bias (separate from True Sentiment)
- neutral
- Conviction
- low
- Published
- 2026-10-07 11:47:00 ET
- Author
- DeltaNeutral staff
TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)
True Sentiment Analysis (Delta 40-60 Options)Options flow (Delta 40-60 only): Call Dollar Vol $600.00 (65.2%), Put Dollar Vol $320.00 (34.8%), Total $920.00. Sentiment: Bullish. Call contracts 6 vs put 2; 1 call trade, 1 put trade. Filter ratio 3.6% of 56 options analyzed.
Pure directional conviction skews call-heavy despite bearish technicals. Near-term expectations implied: speculative upside bet. Divergence: technicals bearish, sentiment bullish — spread engine flagged "Divergence detected between technical indicators and options sentiment; wait for alignment."
Key Statistics: ALEC
Fundamental Snapshot
Valuation
| P/E (trailing) | 17.20 |
| EPS (trailing 12 mo) | $-1.09 |
| Market cap | $199.31M |
| Shares outstanding | 111.7M |
Dividend
| Dividend yield | 0.00% |
Risk & range
| Beta | 1.64 |
| 52-week low | $1.09 |
| 52-week high | $3.40 |
| Historical volatility | 82.2% |
Ownership & trading
| Institutional ownership | 23.2% |
| Average daily volume | 6.3M sh |
Reported figures; no analyst estimates.
📈 Analysis
News Headlines & Context
Recent general-knowledge context for ALEC (Alector Inc., a clinical-stage biotech focused on neurodegeneration):
- Phase 2/3 readout for lead Alzheimer's immuno-neurology candidate expected within coming quarters; any delay or mixed data historically moves the stock sharply.
- Company disclosed ongoing cash-runway management in prior filings; low market cap (~$199M) leaves it sensitive to dilution or partnership headlines.
- Biotech sector rotation and rate-cut expectations have lifted small-cap names, but ALEC has lagged peers on weak technicals.
- No confirmed earnings date in provided data; fiscal year end listed as 2025-12-01, suggesting annual filings cycle near.
- Context: Options flow shows bullish delta-conviction while price sits near 52-week-low zone — possible speculative call positioning ahead of a catalyst not reflected in trend.
Fundamental Analysis
Based strictly on the embedded FUNDAMENTALS data for ALEC:
- Trailing P/E: 17.20; Trailing EPS: -1.09 (negative earnings, P/E derived from skewed base).
- Market Cap: $199,307,745; Shares Out: 111,657,000; Institutional Ownership: 23.21%.
- Dividend Yield: 0.00%; Beta: 1.64 (elevated systemic risk).
- 52-Week High: $3.40; 52-Week Low: $1.09 (current ~$1.79 sits 64% above low).
- Average Volume: 6,310,000; Historical Volatility: 82.15%.
- PEG Ratio, Forward P/E, Revenue, Margins, ROE, D/E, FCF: all null — no growth or profitability metrics available.
- Analyst consensus / target price: null (no coverage data).
Fundamentals show a micro-cap biotech with negative EPS and no disclosed revenue/margin profile. Valuation via trailing P/E is not meaningful given losses. The weak technical picture (price below all SMAs) aligns with absent fundamental strength; only low absolute price and high vol differentiate from a flat bearish read.
Current Market Position
Current price per indicators: $1.79. Daily history shows 2026-10-05 massive volume (87,001,602) with close $1.99 after opening $2.73 — possible offering or news gap-down. 2026-10-06 closed $1.79 (low $1.75, high $2.23, volume 8,744,948). Minute bars 2026-10-06 09:30 open $2.08 fell to $1.98 by 09:50; by 2026-10-07 11:15 price compressed to $1.78 on thinning volume (last bar 6,541).
Intraday momentum is flat-to-down with low volume contraction; no recovery above $1.80 sustained.
Technical Analysis
Technical Indicators
Price below SMA 5 ($1.86) < SMA 20 ($1.97) < SMA 50 ($2.03): bearish alignment, no bullish cross. RSI 42.33 reflects weak momentum (sub-50). MACD negative with histogram -0.01 confirms mild bearish pressure. Bollinger mid $1.97, lower $1.71; price near lower third. 30-day range high $2.76, low $1.75; current $1.79 is 2.3% above 30-day low. ATR 0.20 = ~11% daily swing risk.
True Sentiment Analysis (Delta 40-60 Options)
Options flow (Delta 40-60 only): Call Dollar Vol $600.00 (65.2%), Put Dollar Vol $320.00 (34.8%), Total $920.00. Sentiment: Bullish. Call contracts 6 vs put 2; 1 call trade, 1 put trade. Filter ratio 3.6% of 56 options analyzed.
Pure directional conviction skews call-heavy despite bearish technicals. Near-term expectations implied: speculative upside bet. Divergence: technicals bearish, sentiment bullish — spread engine flagged "Divergence detected between technical indicators and options sentiment; wait for alignment."
Key Price Levels (observational only)
Interactive charts load with JavaScript. This text is the crawlable summary.